| Product Name | MF | CAS | Details |
|---|
| Chicoric acid | C22H18O12 | 6537-80-0 | Details |
| 4-Bromo-5-chloro-2-fluoroaniline | C6H4BrClFN | 116369-24-5 | Details |
| 4,6-dichloro-2-(methoxymethyl)pyrimidine | C6H6Cl2N2O | 1903-92-0 | Details |
| N-(1,3-Dioxaindan-5-ylmethyl)-4-methylcyclohexan-1-amine | C15H21NO2 | 1038286-10-0 | Details |
| [(2-ethoxy-3-pyridinyl)methyl]amine Dihydrochloride | C8H12N2O | 851773-43-8 | Details |
| Ethyl 5-methyl-3-oxo-2,3-dihydro-1H-pyrazole-4-carboxylate | C7H10N2O3 | 125732-40-3 | Details |
| 5-Bromo-3-ethyl-1-benzofuran-2-carboxylic acid | C11H9BrO3 | 86793-66-0 | Details |
| 5-Bromo-4-chloro-3-indolyl b-D-mannopyranoside | C14H15BrClNO6 | 129787-67-3 | Details |
| XDH antibody | Details |
| Cytokine IK antibody | Details |
| 2-Bromo-1-(3,4-dimethoxyphenyl)propan-1-one | C11H13BrO3 | 1835-05-8 | Details |
| ethyl 2-amino-4-(2-fluorophenyl)-7,7-dimethyl-5-oxo-4,6,7,8-tetrahydro2H-chromene-3-carboxylate | C20H22FNO4 | 302901-57-1 | Details |
| SCAMP3 Blocking Peptide | Details |
| 2-Amino-N-(2,2,2-trifluoroethyl)acetamide | C4H7F3N2O | 359821-38-8 | Details |
| Rhodiolin | C25H20O10 | 86831-53-0 | Details |
| 4-(4-Ethylphenyl)benzaldehyde | C15H14O | 101002-44-2 | Details |
| 1-(Cyclohex-1-en-1-yl)-2-methylpropan-2-ol | C10H18O | 76519-80-7 | Details |
| EDIL3 Blocking Peptide | Details |
| CD117 antibody (FITC) | Details |
| ACTB MS Calibrator (25nmol) | Details |
| Eugenol-β-D-glucuronide tetraacetate | C23H28O11 | 2251785-50-7 | Details |
| 3,5-Dimethoxypyridin-4-amine | C7H10N2O2 | 900804-00-4 | Details |
| (2-Oxo-1,3-dioxolan-4-yl)methyl methacrylate | C8H10O5 | 13818-44-5 | Details |
| 3-Methyl-1-(pyridin-2-yl)-4,5-dihydro-1H-pyrazol-5-one | C9H9N3O | 29211-49-2 | Details |
| 1-[(4-Bromophenyl)methyl]-3,5-dimethyl-1H-pyrazol-4-amine hydrochloride | C12H15BrClN3 | 1431963-09-5 | Details |
| 2-Chloro-5-[(dimethylcarbamoyl)amino]benzoic acid | C10H11ClN2O3 | 1250075-49-0 | Details |
| 2-Acetyl-5-methoxyphenyl beta-D-Glucopyranoside | C15H20O8 | 20309-70-0 | Details |
| TMEM161A Blocking Peptide | Details |
| BIM-23127 | C62H71N11O9S2 | 179188-73-9 | Details |
| T56-LIMKi | C19H14F3N3O3 | 924473-59-6 | Details |
| 3-(3-Furan-2-yl-[1,2,4]oxadiazol-5-yl)-propionic acid | C9H8N2O4 | 878437-14-0 | Details |
| (2R,3R,4S,5S)- 2-[(1R)-1,2-Dihydroxyethyl]-3,4-dihydroxy-1-oxa-6,9-diazaspiro[4.5]decane-7,10-dione | Details |
| 3-[(Methoxycarbonyl)Amino]-Benzoic Acid | C9H9NO4 | 209551-66-6 | Details |
| FAM29A Blocking Peptide | Details |
| Pomolic acid 28-O-b-D-glucopyranosyl ester | C36H58O9 | 83725-24-0 | Details |
| Methyl 5-N,4-O-Carbonyl-3,5-dideoxy-2-S-phenyl-2-thio-D-glycero-b-D-galacto-2-nonulopyranosylonate | C17H21NO8S | 934591-79-4 | Details |
| 1-Phenylhex-5-en-3-ol | C12H16O | 60340-28-5 | Details |
| 5-(Benzyloxy)-2-{[(benzyloxy)carbonyl]-amino}-5-oxopentanoic acid | C20H21NO6 | 254980-13-7 | Details |
| DOCK2 antibody | Details |
| 6-(Methylcarbamoyl)pyridine-2-carboxylic acid | C8H8N2O3 | 288616-99-9 | Details |
| Phacolysine sodium salt | C18H10N4Na2O6S2 | 3863-80-7 | Details |
| 4-Chloro-2-cyclopropylquinazoline | C11H9ClN2 | 898044-61-6 | Details |
| 2-Ethoxycyclopropane-1-carboxylic acid | C6H10O3 | 53381-05-8 | Details |
| Cyclopropyl(6-methoxypyridin-3-yl)methanamine | C10H14N2O | 1270387-42-2 | Details |
| 2-[4-(4-Methoxyphenyl)piperazin-1-yl]propanoic acid | C14H20N2O3 | 1039993-12-8 | Details |
| (5-Chloro-1-methyl-1H-benzo[d]imidazol-2-yl)methanol | C9H9ClN2O | 380177-22-0 | Details |
| ROPN1B Blocking Peptide | Details |
| trans-3-Amino-3-methylcyclobutan-1-ol HCl | C5H12ClNO | 1403766-99-3 | Details |
| 3,7-Diamino-2,8-dimethyldibenzothiophene sulfone (contains 2,6-Dimethyl isomer) | C14H14N2O2S | 55011-44-4 | Details |
| YAP1 Blocking Peptide | Details |
| 2-[2-(Benzyloxy)phenoxy]acetic acid | C15H14O4 | 244123-12-4 | Details |
| Methyl 2-amino-3-(3-phenoxyphenyl)propanoate hydrochloride | 2155851-98-0 | Details |
| Poly(3-hydroxybutyric acid-co-3-hydroxyvaleric acid) | C27H42O12X2 | 80181-31-3 | Details |
| 4-Ethylcycloheptan-1-one | C9H16O | 134390-78-6 | Details |
| 7-Fluoro-1-methyl-1,2,3,4-tetrahydroquinoxaline | C9H11FN2 | 1354953-50-6 | Details |
| ACTA1 antibody (HRP) | Details |
| cis-3-Aminocyclobutanemethan-1-ol HCl | C5H11NO | 142733-66-2 | Details |
| Trimethoxy(1H,1H,2H,2H-heptadecafluorodecyl)silane | C13H13F17O3Si | 83048-65-1 | Details |
| 5-Chloro-3-Fluoro-2-Hydrazinopyridine | C5H5ClFN3 | 248255-70-1 | Details |
| 3-Bromo-4-methylanisole | C8H9BrO | 36942-56-0 | Details |
| Murrayanol | C24H29NO2 | 144525-81-5 | Details |
| Ethyl 5-methoxy-1,4-dimethyl-1H-pyrazole-3-carboxylate | C9H14N2O3 | 1239743-27-1 | Details |
| AIPL1 antibody | Details |
| HRas antibody | Details |
| 2-(5-Chloro-1H-1,3-benzodiazol-2-yl)-6-methylphenol | C14H11ClN2O | 1094405-95-4 | Details |
| 2-Hydroxy-4-methoxybenzoic acid | C8H8O4 | 2237-36-7 | Details |
| PF4 antibody | Details |
| [(4-Methoxyphenyl)amino]carbonitrile | C8H8N2O | 13519-16-9 | Details |
| N-[(4-Methylphenyl)methyl]prop-2-en-1-amine | C11H15N | 86926-54-7 | Details |
| CD31 antibody (biotin) | Details |
| 1-[4-(Trifluoromethyl)phenyl]propan-2-amine hydrochloride | C10H13ClF3N | 882-00-8 | Details |
| 4-Chloro-6-(difluoromethyl)-2-methylpyrimidine | C6H5ClF2N2 | 1706452-87-0 | Details |
| 8-Methylquinoline-5-sulfonyl fluoride | C10H8FNO2S | 2137645-05-5 | Details |
| 1-(Cyclobutylmethyl)-1H-pyrazol-4-amine | C8H13N3 | 1225065-25-7 | Details |
| 3-(2,2-Dimethylpropyl)-6-ethyl-[1,2]oxazolo[5,4-b]pyridine-4-carboxylic acid | C14H18N2O3 | 1096901-74-4 | Details |
| 2-Hydroxyisophthalic acid | C8H6O5 | 606-19-9 | Details |
| (2S)-2-{[(tert-Butoxy)carbonyl]amino}-4-[(trifluoromethyl)sulfanyl]butanoic acid | C10H16F3NO4S | 201870-90-8 | Details |
| 2-Bromo-1-[4-(piperidine-1-sulfonyl)phenyl]ethan-1-one | C13H16BrNO3S | 58722-39-7 | Details |
| 2-[4-(Cyanomethyl)phenoxy]acetic acid | C10H9NO3 | 926199-29-3 | Details |
| 4-Ethyl-5-(pyrazin-2-yl)-4H-1,2,4-triazole-3-thiol | C8H9N5S | 37545-29-2 | Details |
| 3-(4,4-Dimethyl-2,5-dioxoimidazolidin-1-yl)propanenitrile | C8H11N3O2 | 27430-50-8 | Details |
| (E)-Tamoxifen | C26H29NO | 13002-65-8 | Details |
| 1-[4-(Pyridin-3-yl)phenyl]ethan-1-amine | C13H14N2 | 885468-60-0 | Details |
| Phth-dPEG?12-Tris (-TFP Ester)3 | Details |
| 2-(((5-bromo(2-pyridyl))amino)methylene)-5,5-dimethylcyclohexane-1,3-dione | C14H15BrN2O2 | 1020252-12-3 | Details |
| Tetrapotassium, 2-[2-[2-[3-(1,3-benzothiazol-2-yl)-7-[bis(carboxylatomethyl)amino]-2-oxochromen-6-yl]oxyethoxy]-N-(carboxylatomethyl )-4-methylanilino]acetate | C33H29K4N3O12S4* | 216453-54-2 | Details |
| 2-[2-(Trifluoromethyl)phenoxy]ethan-1-ol | C9H9F3O2 | 313655-35-5 | Details |
| D-myo-Inositol 1,4,5-triphosphate sodium salt | C6H9Na6O15P3 | 27121-73-9 | Details |
| 4-(2,4-Difluorophenoxy)benzoic acid | C13H8F2O3 | 748183-47-3 | Details |
| (2R,4S,5S)-Lopinavir | C37H48N4O5 | 1217628-64-2 | Details |
| H-VEALYLVCGEEG-OH | Details |
| 2,2,2-Trifluoro-1-{1,5,6,7-tetrahydrospiro[imidazo[4,5-c]pyridine-4,4'-piperidine]-5-yl}ethan-1-one | C12H15F3N4O | 1909306-51-9 | Details |
| FHL2 Blocking Peptide | Details |
| 1,8-Dinitropyrene-d8 | C16D8N2O4 | 121700-15-0 | Details |
| DP-1 | C12H14N2O | 22717-41-5 | Details |
| Stamulumab | 705287-60-1 | Details |
| 2-(Diethylphosphoryl)aniline | C10H16NOP | 1407520-18-6 | Details |
| OLFM2 antibody | Details |
| 6-Methyl-7-(tetramethyl-1,3,2-dioxaborolan-2-yl)quinoxaline | C15H19BN2O2 | 1210047-61-2 | Details |
| (2R)-2-Aminobutane-1-thiol hydrochloride | C4H12ClNS | 114179-99-6 | Details |
| Product Total： Product Page： | ||||
| 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 855 856 857 858 859 860 861 862 863 864 865 866 867 868 869 870 871 872 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 899 900 901 902 903 904 905 906 907 908 909 910 911 912 913 914 915 916 917 918 919 920 921 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 | ||||